These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16511643)

  • 1. Mononeuropathy following subcutaneous interferon-beta injection.
    Capasso M; Caulo M; De Luca G; Magarelli N; Lugaresi A
    J Neurol; 2006 Jul; 253(7):961-2. PubMed ID: 16511643
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
    Lanzillo R; Moccia M; Carotenuto A; Vacchiano V; Satelliti B; Panetta V; Brescia Morra V
    Mult Scler; 2015 Aug; 21(9):1215-6. PubMed ID: 25662354
    [No Abstract]   [Full Text] [Related]  

  • 3. Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection.
    Coghe G; Atzori L; Frau J; Fenu G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler; 2018 Feb; 24(2):231-233. PubMed ID: 28752785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.
    Thouvenot E; Carlander B; Camu W
    Expert Rev Neurother; 2012 Nov; 12(11):1283-91. PubMed ID: 23140228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical reasoning: a 23-year-old woman with paresthesias and weakness.
    Karam C; Khorsandi A; MacGowan DJ
    Neurology; 2009 Jan; 72(2):e5-10. PubMed ID: 19139360
    [No Abstract]   [Full Text] [Related]  

  • 6. Pitfalls in the diagnosis of ulnar neuropathy: remember the deep palmar branch.
    Larner AJ
    Br J Hosp Med (Lond); 2010 Nov; 71(11):654-5. PubMed ID: 21063263
    [No Abstract]   [Full Text] [Related]  

  • 7. The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment.
    Powell A; Myles ML; Yacyshyn E
    Clin Rheumatol; 2008 Nov; 27(11):1467-8. PubMed ID: 18704546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous reactions following subcutaneous beta-interferon-1b injection.
    Ohata U; Hara H; Yoshitake M; Terui T
    J Dermatol; 2010 Feb; 37(2):179-81. PubMed ID: 20175855
    [No Abstract]   [Full Text] [Related]  

  • 9. Thenar motor neuropathy electrophysiological study of 28 cases.
    Mondelli M; Aretini A; Ginanneschi F; Padua L
    J Clin Neurophysiol; 2010 Oct; 27(5):344-9. PubMed ID: 20844445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Livedo reticularis following subcutaneous injection of interferon beta-1b].
    Rodríguez-Vico JS; Mendoza A; Duarte J
    Rev Neurol; 2010 Jul; 51(1):62. PubMed ID: 20568071
    [No Abstract]   [Full Text] [Related]  

  • 11. Origin of ulnar compound muscle action potential investigated in patients with ulnar neuropathy at the wrist.
    Higashihara M; Sonoo M; Imafuku I; Ugawa Y; Tsuji S
    Muscle Nerve; 2010 May; 41(5):704-6. PubMed ID: 20229582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral haemorrhage under interferon-beta therapy.
    Niederwieser G; Bonelli RM; Kammerhuber F; Reisecker F; Költringer P
    Eur J Neurol; 2001 Jul; 8(4):363-4. PubMed ID: 11422436
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?
    Govern EM; Judge EP; Kavanagh E; Gaine S; Lynch T
    Mult Scler Relat Disord; 2015 May; 4(3):284-6. PubMed ID: 26008947
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
    Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
    Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.
    Mikol D; Lopez-Bresnahan M; Taraskiewicz S; Chang P; Rangnow J;
    Mult Scler; 2005 Oct; 11(5):585-91. PubMed ID: 16193898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta-1b (Extavia) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):86-7. PubMed ID: 21045760
    [No Abstract]   [Full Text] [Related]  

  • 17. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
    Wynn D; Kaufman M; Montalban X; Vollmer T; Simon J; Elkins J; O'Neill G; Neyer L; Sheridan J; Wang C; Fong A; Rose JW;
    Lancet Neurol; 2010 Apr; 9(4):381-90. PubMed ID: 20163990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hardly any strength in the left hand. Where is the suspected damage?].
    Schuh A; Hönle W
    MMW Fortschr Med; 2008 Apr; 150(15):6. PubMed ID: 18510105
    [No Abstract]   [Full Text] [Related]  

  • 19. Ulnar nerve palsy-like motor and sensory loss caused by a small cortical infarct.
    Ueno T; Tomiyama M; Haga R; Nishijima H; Kon T; Funamizu Y; Miki Y; Arai A; Suzuki C; Baba M
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e3-4. PubMed ID: 21440458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent injection site reactions from interferon beta 1-b.
    Samuel L; Lowenstein EJ
    J Drugs Dermatol; 2006 Apr; 5(4):366-7. PubMed ID: 16673806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.